# Varenicline for Co-occurring Cannabis and Tobacco Use

> **NCT04595318** · PHASE4 · COMPLETED · sponsor: **Albert Einstein College of Medicine** · enrollment: 7 (actual)

## Conditions studied

- Cannabis Dependence
- Tobacco Dependence

## Interventions

- **DRUG:** Standard clinical care first, followed by standard clinical care and varenicline
- **DRUG:** Standard clinical care and varenicline first, followed by standard clinical care

## Key facts

- **NCT ID:** NCT04595318
- **Lead sponsor:** Albert Einstein College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2024-09-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04595318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04595318, "Varenicline for Co-occurring Cannabis and Tobacco Use". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04595318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*